pharmaphorum September 18, 2023
The Netherlands’ R&D agency TNO has launched a digital health company – AIKON Health – that will focus on the development of wearable devices that will be used to monitor patients with chronic health conditions.
AIKON’s first project is in the area of heart monitoring, drawing on technology developed by TNO researchers at the organisation’s Holst Centre in Eindhoven, which focuses on 3D-printed electronics and biocompatible materials.
Holst scientists have created a prototype of a wearable sensor that is intended for use by people with heart failure who are at risk of deterioration, as a warning system that could allow earlier detection and treatment and prevent readmissions to hospital.
According to TNO, more than 50% of heart failure patients are...